Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues    
Products $ 9,448 $ 10,348
Services 4,033 3,739
Total Revenues 13,481 14,087
Cost of Revenues    
Products 8,054 8,042
Services 2,139 2,098
Total Cost of Revenues 10,193 10,140
Gross Profit 3,288 3,947
Operating Expenses    
Research and development 558 587
Sales and marketing 2,040 2,501
General and administrative 4,658 3,965
Acquisition related costs 3 20
Amortization of intangibles 1,383 1,056
Total Operating Expenses 8,642 8,129
Loss from Operations (5,354) (4,182)
Other Income (Expense)    
Interest expense (684) (143)
Change in fair value of shares to be issued (1)
Change in fair value of derivative liability 56
Other (expense) income (65) 20
Total Other Income (Expense) (693) (124)
Net Loss from Continuing Operations (6,047) (4,306)
Loss from Discontinued Operations, Net of Tax (9)
Net Loss (6,056) (4,306)
Net Loss Attributable to Non-controlling Interest (4) (4)
Net Loss Attributable to Stockholders of Inpixon $ (6,052) $ (4,302)
Net Loss Per Share - Basic and Diluted $ (2.79) $ (2.57)
Weighted Average Shares Outstanding    
Basic and Diluted 2,170,909 1,673,714